Cercle Announces Partnership with Ivy Fertility to Advance Outcomes and Efficiency Across Clinic Network
Top U.S. Fertility Network Selects Cercle to Unify EMRs,
Enhance Patient Conversion, and Improve IVF Success Rates

Ivy Fertility has chosen Cercle as its data & AI/ML partner, implementing Cercle’s platform across its nationwide clinic network. The partnership aims to improve patient outcomes, increase ART conversion, and streamline internal operations across clinical and administrative teams.
A young woman smiling
  • With 14 fertility clinics in the U.S., Ivy operates one of the country’s most respected and fast-growing fertility networks. The group manages care across four distinct EMR systems, creating data silos that have historically challenged clinical coordination and business visibility.

    Ivy’s leadership selected Cercle to unify its disparate data sources and equip its 50+ physicians with decision support tools powered by one of the largest fertility-specific datasets in the world. The integration will enable the automation of reporting, reduce manual overhead, and help Ivy deliver more personalized and efficient care at scale.

    Evelyn Carone, CTO of Ivy Fertility, emphasized the importance of leveraging technology to enhance performance across the network. “As we continue to grow, we’re focused on delivering the best outcomes to our patients and the most efficient workflows to our teams. Cercle gives us the technology backbone to do both — unifying our data, helping us drive better decisions, and ultimately improving the experience for every patient we serve.”
Ashley Finch, COO of Cercle, described the partnership as a milestone for the company’s mission. “Ivy Fertility is one of the most respected names in reproductive care, and we’re thrilled to partner with them. With Cercle, Ivy’s clinicians and operators will gain unified access to their data, the ability to deploy predictive AI tools for IVF success, and the automation they need to operate at scale.”

Juan Carlos Riviero, CEO and Founder of Cercle, adds: “97% of healthcare data remains unstructured and thus largely dormant. The signing of this partnership with Ivy is only the beginning, and we are excited to unlock completely new use cases for them with their data. The possibilities - from systems integration, to personalized medicine, to compliance automation - are literally endless.”

About Ivy Fertility
Ivy Fertility is a globally recognized leader in advanced reproductive technologies, including in-vitro fertilization (IVF), third-party reproduction, and fertility research. Founded in 1989 and headquartered in San Diego, California, Ivy Fertility operates a collaborative network of over 25 fertility centers across the United States, encompassing more than 50 physicians. The network includes renowned clinics such as Dallas IVF, San Diego Fertility Center, Pacific Northwest Fertility, and NOVA IVF. Ivy Fertility is committed to delivering personalized fertility services using advanced technology, with a steadfast focus on patient success. The organization continually contributes to the development of the fertility community through scientific breakthroughs and the adoption of innovative procedures. For more information, visit www.ivyfertility.com.

About Cercle
Cercle™ is an AI company that unlocks women’s healthcare data at scale into insights for optimal patient and business outcomes. Healthcare is inundated with data – but extracting insights from that data is expensive and time consuming. Cercle’s platform, the Cercle Biomedical Graph™, ingests and transforms raw healthcare data into real-time, high-quality insights that women's healthcare providers use to run more efficient businesses and provide more personalized care. Cercle is privately held, and backed by Sheryl Sandberg and Tom Bernthal through their venture fund SBVP, Outsiders Fund, FemHealth Ventures, CGHealth Ventures and Rogue Women’s Fund . For more information, please visit https://www.cercle.ai/.